GlaxoSmithKline Higher On FDA Decision (GSK)

Loading...
Loading...
GlaxoSmithKline plc (ADR)
GSK
is higher in the after hours, after the FDA approved the drug Benylsta, which it co markets with Human Genome (
HGSI
. At last check, shares of GSK were up $1.37 to $39.91, a gain of nearly 4%.
Posted In: NewsFDAAfter-Hours Center
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...